Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial):Design and early dosimetric results of a randomized, multi-centre phase-III study
Full text
Last time updated on 12/08/2017
This paper was published in University of Southern Denmark Research Output.
Having an issue?
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.